Recent studies found that SIRPG could become a potential biomarker for endometrial carcinoma and head and neck squamous cell carcinoma (43, 44) and might promote the immune escape of tumor cells in lung cancer (45). The gene discussed is SIRPG; the disease is head and neck squamous cell carcinoma.